Vesalius Biocapital is a specialist life sciences venture capital investor founded in 2007. The firm raises and manages funds to invest in European companies in the fields of drug development, medical technology, diagnostics, and digital health. Its mission is to contribute to the development of innovative therapies and technologies and to generate attractive returns for its investors. Vesalius Biocapital IV is the company's fourth and current fund, continuing its strategy of backing promising later-stage companies to help them commercialize their products and expand their activities.

Founded in

Luxembourg